Page 471 - IJB-9-6
P. 471

International Journal of Bioprinting                            3D bioprinting of in vitro cartilage tissue model




            feasibility to use this material as a bioink and as a short-  Writing – original draft: Patricia Santos-Beato
            term culture platform to develop human cartilage models   Writing – review & editing: Andrew A. Pitsillides, Alberto
            in vitro. This material, as a bioprintable material to develop   Saiani, Aline Miller, Deepak M. Kalaskar
            human cartilage models, can be applied in personalized
            medicine, fundamental research, or disease modeling.  Ethics approval and consent to participate
                                                               Not applicable.
            5. Conclusion
            In this study, we optimized the bioprinting process of   Consent for publication
            PeptiInk Alpha 1  and demonstrated its potential to   Not applicable.
            manufacture human cartilage models  in vitro.  First,
            we assessed the printability of the material through   Availability of data
            rheological characterization and optimization of printing
            pressures and speeds using a 25G conical nozzle. We   Raw data can be accessed by contacting corresponding
            went on to explore the behavior that primary human   author
            chondrocytes show when encapsulated and 3D-bioprinted
            within Alpha 1. High cell viability, cell self-assembly,   Further disclosure
            and chondrogenic protein expression at the protein and   Part of the entire set of findings has been presented
            mRNA levels were observed in both the control and the   in a conference (European Society of Biomaterials,
            PeptiInk Alpha 1 culture. This material, which can be   September 2022).
            potentially used to 3D-bioprint human cartilage tissue
            models  in  vitro, presents a more ethical and sustainable   References
            alternative than the current 3D-bioprinted cartilage
            in vitro  models. Further work will focus on additional   1.  Gibofsky  A,  2012,  Overview  of  epidemiology,
            assessment of the chondrogenic behavior through ELISA   pathophysiology, and diagnosis of rheumatoid arthritis. Am
            protein quantification, improvement of the material   J Manag Care, 18(13 Suppl): S295–S302.
            stability for long-term cultures, and 3D bioprinting of   2.   Jafarzadeh SR, Felson DT, 2018, Updated estimates suggest
            larger constructs.                                    a much higher prevalence of arthritis in United States adults
                                                                  than previous ones. Arthritis Rheumatol, 70(2): 185–192.
            Acknowledgments
                                                                  https://pubmed.ncbi.nlm.nih.gov/29178176
            This article was written and revised only by the confirmed   3.   Buckwalter JA, Mow VC, Ratcliffe A, 1994, Restoration of
            authors, and no other people contributed to the production   injured or degenerated articular cartilage. J Am Acad Orthop
            of this paper.                                        Surg, 2(4): 192–201.
            Funding                                            4.   O’Hara BP, Urban JP, Maroudas A, 1990, Influence of cyclic
                                                                  loading on the nutrition of articular cartilage. Ann Rheum
            This work was supported by the Engineering and Physical   Dis, 49(7): 536–539.
            Sciences Research Council (EPSRC- EP/S021868/1) Centre   5.   Chang  AA, Reuther  MS, Briggs  KK,  et al., 2012,  In  vivo
            for Doctoral Training.                                implantation  of  tissue-engineered  human  nasal  septal
                                                                  neocartilage constructs: A pilot study.  Otolaryngol Head
            Conflict of interest                                  Neck Surg, 146(1): 46–52.
            The authors declare no conflict of interest.          https://pubmed.ncbi.nlm.nih.gov/22031592
                                                               6.   Jin CZ, Cho JH, Choi BH, et al., 2011, The maturity of tissue-
            Author contributions                                  engineered cartilage in vitro affects the repairability for
                                                                  osteochondral defect. Tissue Eng Part A, 17(23–24): 3057–
            Conceptualization: Patricia Santos-Beato, Andrew A.   3065.
               Pitsillides
            Formal analysis: Patricia Santos-Beato                https://pubmed.ncbi.nlm.nih.gov/21736425
            Funding acquisition: Deepak M. Kalaskar            7.   Neybecker P, Henrionnet C, Pape E,  et al., 2018, In vitro
            Investigation: Patricia Santos-Beato                  and in vivo potentialities for cartilage repair from human
            Supervision: Andrew A. Pitsillides, Alberto Saiani, Aline   advanced knee osteoarthritis synovial fluid-derived
               Miller, Ryo Torii, Deepak M. Kalaskar              mesenchymal stem cells. Stem Cell Res Ther, 9(1): 329.
            Visualization: Patricia Santos-Beato                  https://doi.org/10.1186/s13287-018-1071-2


            Volume 9 Issue 6 (2023)                        463                        https://doi.org/10.36922/ijb.0899
   466   467   468   469   470   471   472   473   474   475   476